Back to search
FDAFDA · Food and drugs·Recall number D-0547-2026

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Published May 20, 2026 · Recall initiated: April 27, 2026

Summary

FDA records drug Class II recall D-0547-2026, published May 20, 2026 and initiated April 27, 2026. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 17,304 100-count bottles; Lot: Lot # 25140859; Exp. Date: Jan 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL SUCCINATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL SUCCINATE
Manufacturer
Ascend Laboratories, LLC
Distributor
U.S. Nationwide
Lot
Lot # 25140859; Exp. Date: Jan 2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01. recalled?

Yes. FDA published recall D-0547-2026 on May 20, 2026. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL SUCCINATE.